These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8947495)

  • 1. Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation.
    Sparatore B; Passalacqua M; Patrone M; Melloni E; Pontremoli S
    Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):253-6. PubMed ID: 8947495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6 kDa protein homologous to the N-terminus of the HMG1 protein promoting stimulation of murine erythroleukemia cell differentiation.
    Sparatore B; Melloni E; Patrone M; Passalacqua M; Pontremoli S
    FEBS Lett; 1996 May; 386(2-3):95-8. PubMed ID: 8647297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation.
    Passalacqua M; Zicca A; Sparatore B; Patrone M; Melloni E; Pontremoli S
    FEBS Lett; 1997 Jan; 400(3):275-9. PubMed ID: 9009213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells.
    Petrak J; Myslivcova D; Man P; Cmejlova J; Cmejla R; Vyoral D
    Exp Hematol; 2007 Feb; 35(2):193-202. PubMed ID: 17258068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular release of the 'differentiation enhancing factor', a HMG1 protein type, is an early step in murine erythroleukemia cell differentiation.
    Melloni E; Sparatore B; Patrone M; Pessino A; Passalacqua M; Pontremoli S
    FEBS Lett; 1995 Jul; 368(3):466-70. PubMed ID: 7635200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in E2F DNA-binding activity during induced erythroid differentiation.
    Richon VM; Venta-Perez G
    Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic RAS genes impair erythroid differentiation of erythroleukaemia cells.
    Zaker F; Darley RL; al Sabah A; Burnett AK
    Leuk Res; 1997 Jul; 21(7):635-40. PubMed ID: 9301684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in calcium influx affect the differentiation of murine erythroleukaemia cells.
    Sparatore B; Pessino A; Patrone M; Passalacqua M; Melloni E; Pontremoli S
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):285-90. PubMed ID: 7826342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities.
    Aroor AR; Singh LP; Wahba AJ
    Exp Hematol; 1995 Oct; 23(11):1204-11. PubMed ID: 7556531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the growth kinetics of murine erythroleukaemia cells following commitment to terminal differentiation.
    Fibach E
    Cell Tissue Kinet; 1987 Nov; 20(6):617-24. PubMed ID: 3502930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dephosphorylation of Vav is associated with the induction of mouse erythroleukemia cell differentiation: effects of orthovanadate and levamisole.
    Scher BM; Wei XJ; Waxman S; Scher W
    Int J Oncol; 1998 Jun; 12(6):1307-13. PubMed ID: 9592191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of Ran GTPase during HMBA-induced differentiation in murine erythroleukemia cells.
    Vanegas N; García-Sacristán A; López-Fernández LA; Párraga M; del Mazo J; Hernández P; Schvartzman JB; Krimer DB
    Leuk Res; 2003 Jul; 27(7):607-15. PubMed ID: 12681360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotype mimicry by a differentiation antigen on Friend erythroleukemia cells.
    Ardman B; DiMambro E; Levy SB; Schwartz RS
    J Immunol; 1987 Sep; 139(6):2038-43. PubMed ID: 3476672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells.
    Del Rosso M; Pucci M; Fibbi G; Dini G
    Br J Haematol; 1987 Jul; 66(3):289-94. PubMed ID: 3040071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
    Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procaine inhibits the erythroid differentiation of MEL cells by blocking commitment: possible involvement of calcium metabolism.
    Tsiftsoglou AS; Mitrani AA; Housman DE
    J Cell Physiol; 1981 Sep; 108(3):327-35. PubMed ID: 6793604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new group of potent inducers of differentiation in murine erythroleukemia cells.
    Reuben RC; Wife RL; Breslow R; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):862-6. PubMed ID: 1062798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
    Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
    Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.